Search
for

    Sort by

    Research 151–180 of 1000+

    1. Comparative safety profiles of baricitinib and tofacitinib in the treatment of adult alopecia areata: a pharmacovigilance study based on the FAERS database Frontiers in Public Health · 2026
    2. The Safety and Efficacy of a Proprietary Bioactive Fatty Acids Extract From Saw Palmetto ( <i>Serenoa repens</i> ) for Promoting Hair Growth and Reducing Hair Loss in Adults With Self‐Perceived Thinning Hair: 90‐Day Results Journal of Cosmetic Dermatology · 2025
    3. The safety and efficacy of finasteride for transgender men with androgenetic alopecia: a case series Journal of Medical Case Reports · 2025
    4. LB1101 Evaluating the cardiovascular safety of low-dose oral minoxidil in patients with non-scarring alopecia: A retrospective cohort study Journal of Investigative Dermatology · 2025
    5. Comprehensive Safety Exposure‐Response Analysis to Support Ritlecitinib Dose Selection CPT Pharmacometrics & Systems Pharmacology · 2025
    6. Chemical Safety and Technical Decision-Making in Hair Procedures: A Professional and Scientific Perspective Zenodo (CERN European Organization for Nuclear Research) · 2025
    7. Chemical Safety and Technical Decision-Making in Hair Procedures: A Professional and Scientific Perspective Zenodo (CERN European Organization for Nuclear Research) · 2025
    8. Evaluating safety and ethical implications of androgenetic alopecia treatments: a comparison of direct-to-consumer platforms and dermatologist visits Journal of the American Academy of Dermatology · 2024
    9. Clinical Safety and Efficacy of Dual Wavelength Low-Level Light Therapy in Androgenetic Alopecia: A Double-Blind Randomized Controlled Study Dermatologic Surgery · 2024
    10. Integrated Safety Analysis of Ritlecitinib, an Oral JAK3/TEC Family Kinase Inhibitor, for the Treatment of Alopecia Areata from the ALLEGRO Clinical Trial Program American journal of clinical dermatology · 2024
    11. 42736 Safety Assessments in the Multinational Phase 3 THRIVE-AA1 Trial with CTP-543 (Deuruxolitinib) in Adult Patients with Moderate to Severe Alopecia Areata Journal of the American Academy of Dermatology · 2023
    12. Gestational safety: No time for a pregnant pause Journal of The American Academy of Dermatology · 2023
    13. The Safety and Efficacy of Processed Fat, Adipose Stromal Vascular Fraction (SVF), Platelet-Rich Plasma (PRP), and Nano-Fraction in Fat Grafting to Faces/Hands and Hair Stimulation 2019
    14. P153 : Safety and Efficacy of botulinum toxin on male pattern baldness 프로그램북(구 초록집) · 2018
    15. THU0189 Safety of four treatment regimens in early rheumatoid arthritis Poster presentations · 2017
    16. The Safety and Efficacy of Processed Fat, Adipose-Derived Stromal Vascular Fraction (SVF) and Platelet-Rich Plasma (PRP) in Fat Grafting: Clinical Implications for Aesthetic Facial Volume/Skin Rejuvenation and Hair Stimulation 2017
    17. 556 Safety and efficacy of leukocyte-rich platelet-rich plasma in the treatment of cicatricial alopecia Journal of Investigative Dermatology · 2020
    18. Efficacy and safety of ritlecitinib in adults and adolescents with alopecia areata: a randomised, double-blind, multicentre, phase 2b–3 trial The Lancet · 2023 · 227 citations
    19. Efficacy and safety of omeprazole for severe gastroesophageal reflux in children The Journal of Pediatrics · 1993 · 158 citations
    20. Efficacy and Safety of Finasteride Therapy for Androgenetic Alopecia Archives of Dermatology · 2010 · 152 citations
    21. Efficacy and safety of a novel anti‐HER2 therapeutic antibody RC48 in patients with HER2‐overexpressing, locally advanced or metastatic gastric or gastroesophageal junction cancer: a single‐arm phase II study Cancer Communications · 2021 · 147 citations
    22. Efficacy and Safety of a Low-level Laser Device in the Treatment of Male and Female Pattern Hair Loss: A Multicenter, Randomized, Sham Device-controlled, Double-blind Study American Journal of Clinical Dermatology · 2014 · 147 citations
    23. Efficacy and safety of a new clobetasol propionate 0.05% foam in alopecia areata: a randomized, double‐blind placebo‐controlled trial Journal of the European Academy of Dermatology and Venereology · 2006 · 114 citations
    24. Efficacy and safety of the oral Janus kinase inhibitor baricitinib in the treatment of adults with alopecia areata: Phase 2 results from a randomized controlled study Journal of The American Academy of Dermatology · 2021 · 66 citations
    25. The efficacy and safety of 5α-reductase inhibitors in androgenetic alopecia: a network meta-analysis and benefit–risk assessment of finasteride and dutasteride Journal of Dermatological Treatment · 2013 · 66 citations
    26. Efficacy and safety of mycophenolate mofetil for lichen planopilaris Journal of The American Academy of Dermatology · 2010 · 66 citations
    27. Efficacy and safety of deuruxolitinib, an oral selective Janus kinase inhibitor, in adults with alopecia areata: Results from the Phase 3 randomized, controlled trial (THRIVE-AA1) Journal of the American Academy of Dermatology · 2024 · 63 citations
    28. Effectiveness and safety of low-dose oral minoxidil in male androgenetic alopecia Journal of The American Academy of Dermatology · 2019 · 52 citations
    29. Efficacy and safety of ritlecitinib in adolescents with alopecia areata: Results from the ALLEGRO phase 2b/3 randomized, double‐blind, placebo‐controlled trial Pediatric Dermatology · 2023 · 48 citations
    30. Efficacy and safety of diphenylcyclopropenone alone or in combination with anthralin in the treatment of chronic extensive alopecia areata: A retrospective case series Journal of the American Academy of Dermatology · 2015 · 44 citations